Dr. Reuven Schore, MD

  • Washington, DC
  • Pediatric hematology and oncology physician
NPI1033204227
Publications
33
Clinical trials
2
Hospital affiliations
1
Industry payments
$6,113
Medical group
1
Practice address
111 Michigan Ave, NW, Washington, DC 20010
Practice phone
Call (202) 476-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Children's National Hospital

Hospital · Washington, District of Columbia

See all 3 affiliations

Find Dr. Schore's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Reuven Schore is a pediatric hematology and oncology physician in Washington, District of Columbia

Dr. Schore practices at Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital.

Dr. Schore's NPI, 1033204227, was assigned on October 4, 2006. Dr. Schore graduated from SUNY Downstate Health Sciences University in 2000. Dr. Schore holds District of Columbia license MD036188.

NPI and contact details
NPI enumeration date
October 4, 2006
NPI status
Active
Practice phone
(202) 476-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Medical school graduation
2000

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Reuven Schore practices at Children's National Hospital in Washington, District of Columbia

Dr. Schore's primary practice is Children's National Hospital, at 111 Michigan Ave, NW, Washington, DC 20010 in The District County. The practice phone is (202) 476-5000.

Source: Dmand AI Affiliation Data

Dr. Reuven Schore is affiliated with 2 sites of care and 1 medical group

Dr. Schore's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. The medical group on file is Children's National Hospital. Dmand AI also links Dr. Schore to 1 more dialysis center, named with a free account.

See all 3 affiliations for Dr. Schore

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Reuven Schore's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schore practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Children's National HospitalAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Schore practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Children's National Hospital and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Reuven Schore is one of 65 pediatric hematologys and oncology physicians in District of Columbia

Pediatric hematology-oncology is Dr. Schore's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Schore is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Schore's licenses on file in 5 states: District of Columbia, New York, Virginia, Maryland and Ohio.

Specialties and state licenses

  • Pediatric hematology and oncology, District of ColumbiaPrimaryLicense MD036188 · 2006 to 2026 · taxonomy 2080P0207X
  • New York license2001 to 2026
  • Virginia license2007 to 2026
  • Maryland license2007 to 2025
  • Ohio license2003 to 2006

Pediatric hematologys and oncology physicians near Dr. Schore

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Reuven Schore's patients have a median age of 10

Across all payers, Dmand AI patient panel data puts Dr. Schore's median patient age at 10, with 53% women.

Dr. Schore's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 10

Patient panel by sex, all payers

  • Women53%
  • Men47%

Source: Dmand AI Patient Panel Data

Dr. Reuven Schore has 33 publications on record

Dmand AI links 33 papers to Dr. Schore, published from 2014 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual and Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Dr. Schore has published most often in Pediatr Blood Cancer. Dr. Schore's most frequent co-authors are Anne L. Angiolillo, MD, Stephen P. Hunger, MD and Elizabeth A. Raetz, MD.

Papers33
Years published2014 to 2025

Dr. Schore's papers by year, 2014 to 2025

Topics Dr. Schore writes about most

  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Neoplasm, Residual
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
  • Antineoplastic Agents
  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Vincristine
  • Dexamethasone

Dr. Schore's most frequent co-authors

Recent publications by Dr. Schore

See all 33 publications and co-authors

See who Dr. Schore researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schore works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Reuven Schore has worked on 2 clinical trials

Dmand AI links Dr. Schore to 2 clinical trials, 2 of them phase 1 studies. Conditions studied include Leukemia, Leukemia, Myeloid, Acute and Hematologic Diseases.

Conditions in Dr. Schore's trials

  • Leukemia
  • Leukemia, Myeloid, Acute
  • Hematologic Diseases
  • Leukemia, Myeloid

Investigators on the most trials with Dr. Schore

Recent clinical trials with Dr. Schore

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Reuven Schore received $6,113 in industry payments from 2017 to 2021

CMS Open Payments shows 6 general payments to Dr. Schore from 3 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 93% of the total. Jazz Pharmaceuticals Inc. paid the most, $3,840.

General payments to Dr. Schore by program year, 2017 to 2021

General payments to Dr. Schore by kind, 2017 to 2021

$6.1Kin total
  • Consulting fees$5,70893%
  • Travel and lodging$2985%
  • Entertainment$1082%

Companies that paid Dr. Schore the most, 2017 to 2021

Share is of all general payments to this clinician.

See all payments to Dr. Schore

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Reuven Schore graduated from SUNY Downstate Health Sciences University

Dr. Schore graduated from SUNY Downstate Health Sciences University in 2000. Dr. Schore is a member of AOA, ASCO and ASH.

  1. Medical schoolSUNY Downstate Health Sciences University
  2. Board certified in pediatric hematology-oncologyAmerican Board of Pediatrics
  3. Board certified in pediatricsAmerican Board of Pediatrics
  4. Board certified in clinical informaticsAmerican Board of Preventive Medicine

Source: Dmand AI Professional Profile Data

Dr. Reuven Schore accepts plans from 9 insurance carriers

Dr. Schore is in network with 9 carriers, including Aetna, United Healthcare and Molina. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.

  • Aetna
  • United Healthcare
  • Molina
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • CareFirst BlueCross BlueShield
  • Elevance
  • HCSC
  • +1 more carriersWith a free account

Plan types Dr. Schore accepts, by number of carriers

  1. Medicare4
  2. PPO4
  3. HMO3
  4. POS3
  5. EPO2
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Reuven Schore's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Reuven Schore

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Reuven Schore's NPI number?

Dr. Reuven Schore's NPI number is 1033204227. It was assigned on October 4, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Reuven Schore?

Dr. Reuven Schore is a pediatric hematology and oncology physician in Washington, District of Columbia. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. Reuven Schore practice?

Dr. Schore practices at 111 Michigan Ave, NW, Washington, DC 20010. Dr. Schore's primary practice is Children's National Hospital in Washington, District of Columbia, part of Children's National Hospital. Dmand AI also links Dr. Schore to 1 dialysis center.

What is Dr. Reuven Schore's office phone number?

The practice phone on file for Dr. Schore is (202) 476-5000.

What is Dr. Reuven Schore's medical license number?

Dr. Schore holds District of Columbia license MD036188, one of the licenses on file in 5 states.

Which states has Dr. Reuven Schore been licensed in?

Dmand AI has state licenses on file for Dr. Schore in District of Columbia (2006 to 2026), New York (2001 to 2026), Virginia (2007 to 2026), Maryland (2007 to 2025) and Ohio (2003 to 2006).

Which hospitals is Dr. Reuven Schore affiliated with?

Dr. Schore practices at Children's National Hospital in Washington, District of Columbia.

What medical group is Dr. Reuven Schore part of?

Dr. Schore is linked to Children's National Hospital.

Is Dr. Reuven Schore board certified?

Yes. Dr. Schore is board certified in pediatric hematology-oncology by the American Board of Pediatrics.

Where did Dr. Reuven Schore go to medical school?

Dr. Schore graduated from SUNY Downstate Health Sciences University in 2000.

Show 5 more questionsShow fewer questions

Has Dr. Reuven Schore received payments from drug or device companies?

CMS Open Payments shows $6,113 in general payments to Dr. Schore from 3 companies from 2017 to 2021. The largest total came from Jazz Pharmaceuticals Inc.

How long has Dr. Reuven Schore been practicing?

Dr. Schore graduated from medical school in 2000, 26 years ago.

Does Dr. Reuven Schore do research?

Dmand AI links 33 publications to Dr. Schore, published from 2014 to 2025. Dr. Schore has worked on 2 clinical trials.

Who does Dr. Reuven Schore publish with?

Dr. Schore's most frequent co-authors are Anne L. Angiolillo, MD (13 shared papers), Stephen P. Hunger, MD (13 shared papers) and Elizabeth A. Raetz, MD (12 shared papers).

What insurance does Dr. Reuven Schore accept?

Dr. Schore is in network with 9 carriers, including Aetna, United Healthcare and Molina. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in District of Columbia by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)